COVID-19 is an important new infectious disease that affects \>150 countries worldwide. This respiratory infection is a public health emergency to be managed. As a new disease, there is limited knowledge of treatment. In general, many drugs are tests for possible efficacy in disease management. The widely used antiviral drugs include oseltamivir and anti-HIV drugs.\[[@ref1]\] In medical science, there are also attempts to find herbs, natural products, which might be effective in the treatment of the coronavirus disease.\[[@ref2]\] In the previous report, an important target that is useful for the treatment of coronavirus disease is tyrosine kinase.\[[@ref3]\] Any herbs that pose anti-tyrosine kinase property might be useful for the treatment of COVID-19. Here, the authors perform a pharmacoinformatics study to search for herbs that have antipeptidase property and might be useful. Using the same database mining technique as in the referencing publication,\[[@ref4]\] the PubMed database is used as a primary tool for data mining. According to data mining, there are at least herbs that present anti-tyrosine kinase properties and might be useful for the treatment of COVID-19. Those herbs are *Hesperethusa crenulata*,\[[@ref5]\] *Perilla frutescens*,\[[@ref6]\] *Ephedra equisetina*,\[[@ref7]\] *Shiraia bambusicola*,\[[@ref8]\] *Panax ginseng*\[[@ref9]\] and *Carthamus tinctorius L* \[[Table 1](#T1){ref-type="table"}\].\[[@ref10]\] Of interest, those herbs are the classical well-known herbs in East Asia, where the COVID-19 first emerged. The present data mining is only to roughly include potential herbs for further studies on the possible usefulness in the management of COVID-19. Some of these herbs are already confirmed for their advantages in the management of viral respiratory infections. For example, *E. equisetina* and *P. ginseng* are confirmed for its anti-influenza property.\[[@ref11] [@ref12]\]

###### 

Local herbs that have potentials for the treatment of coronavirus disease 2019

  Herbs                                                                                                                      Origin                      Ehnopharmacological indication   Administration   Dose/day\*
  -------------------------------------------------------------------------------------------------------------------------- --------------------------- -------------------------------- ---------------- --------------
  *Hesperethusa crenulata Perilla frutescens Ephedra equisetina Shiraia bambusicola Panax ginseng Carthamus tinctorius L.*   Myanmar                     Dermatological disorder          Skin paste       Powder paste
  Myanmar, China                                                                                                             Gastrointestinal disorder   Ingestion                        2.5 g            
  Japan                                                                                                                      Cardiovascular disorder     Ingestion                        30 mg            
  China                                                                                                                      Respiratory disorder        Ingestion                        25 mg            
  Korea, China                                                                                                               Many disorder30             Ingestion                        6 g              
  Korea                                                                                                                      Cardiovascular disorder     Ingestion                        30 g             

\*Dose is referred to local ethnopharmacological practice
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